Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 66 | 0 | 19 | 0 | €846.00 | €883.50 | 4.433% |
| Amgen Inc. | 28 | 0 | 4 | 0 | €291.80 | €300.61 | 3.019% |
| Repligen Corp. | 14 | 0 | 1 | 0 | €118.30 | €182.96 | 54.658% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €19.70 | - | - |
| Halozyme Therapeutics Inc. | 20 | 0 | 5 | 0 | €48.90 | €52.75 | 7.869% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €261.30 | €315.00 | 20.551% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €6.50 | €8.75 | 34.615% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.40 | - | - |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €24.00 | €28.29 | 17.878% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.78 | €11.05 | 90.996% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.36 | - | - |
| Verastem Inc. | 11 | 0 | 4 | 0 | €2.78 | €19.20 | 590.644% |
| Neurocrine Bioscience | 33 | 0 | 4 | 0 | €128.55 | €140.87 | 9.582% |
| Geron Corp. | 16 | 0 | 4 | 0 | €3.96 | €5.56 | 40.541% |
| Sarepta Therapeutics | 8 | 0 | 7 | 0 | €147.55 | €190.00 | 28.770% |
| United Therapeutics | 22 | 0 | 3 | 0 | €297.30 | €289.92 | -2.482% |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 1 | 0 | €79.28 | €102.63 | 29.453% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €10.33 | €27.02 | 161.660% |
| Lexicon Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €1.57 | €7.66 | 386.372% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.95 | €26.01 | 24.136% |
| Innoviva Inc. | 4 | 0 | 1 | 0 | €15.20 | €30.00 | 97.368% |
| Exact Sciences | 16 | 0 | 3 | 0 | €39.44 | €78.89 | 100.055% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.89 | €8.35 | 342.415% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €6.00 | €19.50 | 224.975% |